Dermapharm Holding SE Approves EUR 0.90 Dividend Per Share

Dermapharm Holding SE announced a dividend distribution of EUR 0.90 per share after its Annual General Meeting. Held in Grünwald on June 26, 2025, 14.6% of shareholders attended and supported all management proposals. Actions of the Board of Management and Supervisory Board were ratified with a 99.2% and 89.4% majority, respectively.

The approved dividend amounts to EUR 48.5 million, reflecting 43% of the eligible net profit. Grant Thornton AG was re-elected as the fiscal auditor, with RSM Ebner Stolz appointed for sustainability auditing, contingent on regulatory changes.

For 2025, Dermapharm confirmed revenue predictions between EUR 1,160-1,200 million and anticipates an adjusted EBITDA of EUR 322-332 million. The company aims for profitable growth, emphasizing branded pharmaceuticals and sustainable supply chain development.